Archives of General Psychiatry · 1984 · 184 citations · 37 references
MedicineNeurosciencePharmacologyBehavioral PharmacologyNeuropharmacologyPsychopharmacologyAnxiolytic PharmacologyAnxiolytic PharmacotherapyAnxiolytic TherapyAgitationBenzodiazepine AntagonismBenzodiazepine Receptor AgonistsPharmacodynamic MechanismsPreclinical Anxiety ModelsPropranolol Therapy
beta-Carboline-3-carboxylic acid ethyl ester (beta-CCE) binds with high affinity to brain benzodiazepine receptors and has potent behavioral and physiologic effects in primates. Dose-related increases in behavioral agitation, plasma cortisol level, BP, and heart rate were observed after administration of doses between 50 and 500 micrograms/kg of beta-CCE to rhesus monkeys. All of these effects were blocked by pretreatment with diazepam. Pretreatment with clonidine hydrochloride and propranolol hydrochloride, both of which have been reported to have anxiolytic actions in man, attenuated only selective aspects of the response to beta-CCE. The behavioral, endocrine, and physiologic effects of low doses of beta-CCE in monkeys are similar to those observed in anxious patients or normal subjects under anxiety-provoking or stressful situations. Administration of benzodiazepine receptor active antagonists such as beta-CCE to primates may, therefore, provide a valid and reproducible model of human anxiety that could be used to investigate specific biologic aspects of anxiety disorders.
37
Benzodiazepine Receptor: Demonstration in the Central Nervous System
H Möhler, Toshikazu Okada · Science · 1977 · 1.7K citations
Medicine, Neuroscience, Pharmacology +11
Benzodiazepine receptors in rat brain
Richard F. Squires · Nature · 1977 · 1.5K citations
Medicine, Neuroscience, Pharmacology +10
The Pharmacological Basis of Therapeutics
Alfred G. Gilman · Optometry and Vision Science · 1976 · 1.3K citations
Lactate Metabolism in Anxiety Neurosis
Ferris N. Pitts, James N. McClure · New England Journal of Medicine · 1967 · 654 citations